bromocriptine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martino, V; Norsa, A | 1 |
| Senogles, SE | 1 |
1 trial(s) available for bromocriptine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status.
Topics: Adult; Aged; Bromocriptine; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Female; Humans; Male; Melatonin; Middle Aged; Neoplasm Staging; Quality of Life; Retinoids; Somatostatin; Survival Analysis; Time Factors; Vitamin D | 2006 |
1 other study(ies) available for bromocriptine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69.
Topics: Bromocriptine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Dopamine Agonists; Gene Expression; Humans; Lung Neoplasms; Pertussis Toxin; Phospholipase D; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Thymidine | 2007 |